Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide

This publication has 10 references indexed in Scilit:

• Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats
  Food and Cosmetics Toxicology, 1973
• Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid
  Biochemical Pharmacology, 1972
• Vitamin E and hepatotoxic agents
  British Journal of Nutrition, 1970
• MICROSOMAL-ENZYME STIMULATION IN MAN BY B.H.T.
  The Lancet, 1970
• Chemical protection against aging
  Inflammation Research, 1969
• Effect of Neonatal Androgen and Estrogen Injection on Liver Tumor Induction byN-Hydroxy-N-2-fluorenylacetamide and on the Metabolism of the Carcinogen in Rats
  Endocrinology, 1968
• Separation of the urinary metabolites of N-2-fluorenylacetamide on columns of DEAE-cellulose anion exchanger
  Biochemical Pharmacology, 1967
• Liver response tests. III. Liver enlargement and stimulation of microsomal processing enzyme activity
  Food and Cosmetics Toxicology, 1965
• Liver response tests. IV. Application to short-term feeding studies with butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA)
  Food and Cosmetics Toxicology, 1965
• Chemistry, Carcinogenicity, and Metabolism of 2-Fluorenamine and Related Compounds
  Published by Elsevier ,1958